Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Blocking interferon-gamma might help treat various autoimmune diseases.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Low BMI and cold exposure increase the risk of chilblains.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Dermoscopy and trichoscopy are useful for diagnosing skin signs in Dermatomyositis.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Systemic lupus erythematosus is diagnosed earlier in males than females.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

42% of SLE patients had thyroid issues, mostly hypothyroidism.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

SLE significantly affects daily life, especially through fatigue and joint pain, highlighting the need for better treatments.